Modius Sleep
Commercial- Indications
- Chronic Insomnia
Company intelligence / Profile preview
Neurovalens
Belfast, Northern Ireland, United Kingdomneurovalens.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Neurovalens has achieved FDA clearance for its Modius Sleep device to treat chronic insomnia and Modius Calm/Stress to treat generalized anxiety disorder. Clinical trials have shown that repeated electrical vestibular nerve stimulation reduces severity in moderate to severe insomnia. The company’s technology offers a non-drug, non-invasive alternative with demonstrated efficacy in randomized controlled trials. A neuromodulation device targeting type 2 diabetes ("Vestal") appears to be in development but not yet commercialized.
- Therapeutic areas
- PsychiatryEndocrinology
- Modalities
- DeviceNon-pharmacological therapyNeuromodulation (Neurostimulation)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Beyond the preview
Go deeper on Neurovalens.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neurovalens.